Management of diabetic hypertensives

Abstract

Hypertension occurs twice as commonly in diabetics than in comparable nondiabetics. Patients with both disorders have a markedly higher risk for premature microvascular and macrovascular complications. Aggressive control of blood pressure (BP) reduces both micro- and macrovascular complications. In diabetic hypertensives, angiotensin converting enzyme inhibitors (ACEIs) are the first line in management of hypertension, and can be replaced by angiotensin II receptor blockers (ARBs) if patients are intolerant of them. Recent studies suggest ARBs to be on par with ACEI in reducing both macro- and microvascular risks. Adding both these agents may have a beneficial effect on proteinuria, but no extra macrovascular risk reduction. Thiazides can also be used as first line drugs, but are better used along with ACEI/ARBs. Beta-blockers [especially if the patient has coronary artery disease] and calcium channel blockers are used as second line add-on drugs. Multidrug regimens are commonly needed in diabetic hypertensives. Achieving the target BP of <130/80 is the priority rather than the drug combination used in order to arrest and prevent the progression of macro- and microvascular complications in diabetic hypertensives.

Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria

“…Blood pressure control is essential to avoid the progression from uncomplicated diabetes to diabetic nephropathy [2], and angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are two classes of agents that could effectively reduce the incidence of end-stage kidney disease [3, 4]. The current treatment guidelines recommend ACEI or ARB monotherapy for blood pressure control among non-pregnant diabetic patients with kidney disease [5].…”

Understanding the Clinical Relationship Between Diabetic Retinopathy, Nephropathy, and Neuropathy: A Comprehensive Review

“…Treatment of diabetes and high blood pressure: The initial step in managing DN involves effectively controlling diabetes and high blood pressure. This is typically achieved through lifestyle modifications, dietary adjustments, and medications such as ACE inhibitors and ARBs [ 32 ].…”

The dirty dozen of diabetes

“…Because of this, and their nephroprotective and cardioprotective effects, these molecules have become drugs of first choice in hypertension associated with diabetes. [13] While, currently, they cannot be recommended for the primary prevention of diabetes, the future holds promise for RAS-based intervention in diabetes care. RAS, therefore, should justifiably be included as part of the Dirty Dozen.…”